Verition Fund Management
ROIV icon

Verition Fund Management’s Roivant Sciences ROIV Stock Holding History

Verition Fund Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-728,997
Closed -$15.8M – 3339
2025
Q4 		$15.8M Buy
728,997
+99,500
+16% +$1.96M 0.06% 262
2025
Q3 		$9.52M Buy
629,497
+130,927
+26% +$1.62M 0.04% 550
2025
Q2 		$5.62M Buy
498,570
+167,744
+51% +$1.82M 0.03% 989
2025
Q1 		$3.34M Sell
330,826
-44,732
-12% -$484K 0.02% 1189
2024
Q4 		$4.44M Buy
+375,558
New +$4.44M 0.02% 974
2024
Q3 		– Sell
-16,360
Closed -$173K – 3475
2024
Q2 		$173K Buy
+16,360
New +$179K ﹤0.01% 2637
2023
Q2 		– Sell
-15,946
Closed -$118K – 2485
2023
Q1 		$118K Buy
+15,946
New +$131K ﹤0.01% 1894

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Verition Fund Management's ROIV Position: Q1 2026 in Review

Verition Fund Management sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 728,997 shares — an estimated $15.8M sold.

Verition Fund Management first reported a position in ROIV in Q1 2023 and held it in 7 quarters. The position peaked at $15.8M in Q4 2025. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Verition Fund Management reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 728,997 Roivant Sciences shares in Q1 2026, an estimated $15.8M.
  • Verition Fund Management first reported a position in Roivant Sciences in Q1 2023 and held it in 7 quarters.
  • Verition Fund Management's Roivant Sciences position peaked at $15.8M in Q4 2025.
  • 444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.